This opportunity is no longer accepting applications.
grant admin_console 964838

LEAP Grants: RUNX1-FPD Leukemia Interception & Prevention Research

The LEAP program (RUNX1 Research Program + American Cancer Society) funds investigator-initiated projects to discover and advance cancer interception or prevention strategies for individuals with RUNX1 familial platelet disorder (RUNX1-FPD). Funded work should focus on (1) mechanistic studies of leukemogenic steps affecting RUNX1-mutant HSPCs—including cell-autonomous and cell-nonautonomous fa…

Background The formation of cancer is orchestrated by a confluence of external, cell-nonautonomous, factors and internal, cell-autonomous, factors. Discovering medical interventions that can disrupt this complex interplay of factors is challenging but necessary.

In the bone marrow, the ac…

Funding Source

Agency: American Cancer Society

Awards & funding

Total Funding: $2.6M
Award Ceiling: $1.7M
Award Floor: $860,000
Total Awards Given 3

Eligibility

You ARE eligible to submit a proposal if you:

  • Work at a US academic institution or eligible nonprofit
  • Are a full-time independent investigator at any career stage

Dates

Application Deadline: October 29, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.